Infant lung function tests as endpoints in the ISIS multicenter clinical trial in cystic fibrosis

Journal of Cystic Fibrosis

Volumn 15, Issue 3, 2016, Pages 386-391

  Davis, Stephanie D ^a,d   Ratjen, Felix ^b   Brumback, Lyndia C ^c   Johnson, Robin C ^d   Filbrun, Amy G ^e   Kerby, Gwendolyn S ^f   Panitch, Howard B ^g   Donaldson, Scott H ^d   Rosenfeld, Margaret ^h,u   Davis, Stephanie ⁱ   Faro, Albert ^j   Filbrun, Amy ^k   Hiatt, Peter ^l   Kerby, Gwendolyn ^m   McCoy, Karen ⁿ   McDowell, Karen ^o   Acton, James ^o   Milla, Carlos ^p   Panitch, Howard ^q   Prestridge, Adrienne ^r   Radford, Peggy ^s   Ren, Clement ^t   Sharp, Jack ^v   more..

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f University of Colorado Denver and Children s Hospital Colorado   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF NORTH CAROLINA   (United States)

^j ST LOUIS CHILDREN S HOSPITAL   (United States)

^k UNIVERSITY OF MICHIGAN   (United States)

^l BAYLOR COLLEGE OF MEDICINE   (United States)

^m CHILDREN S HOSPITAL   (United States)

ⁿ NATIONWIDE CHILDREN S HOSPITAL   (United States)

^o CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^p STANFORD UNIVERSITY   (United States)

^q CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^r CHILDREN'S MEMORIAL HOSPITAL   (United States)

^s PHOENIX CHILDREN'S HOSPITAL   (United States)

^t UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^u SEATTLE CHILDREN S HOSPITAL   (United States)

^v CHILDREN S HOSPITAL OF BUFFALO   (United States)

more..

Author keywords

FEV; Forced expiratory flow rates; Pulmonary function tests

Indexed keywords

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EXPIRATORY RESERVE VOLUME; FEASIBILITY STUDY; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FUNCTIONAL RESIDUAL CAPACITY; HUMAN; INFANT; INFANT DISEASE; LUNG FIBROSIS; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; MULTICENTER STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SECONDARY ANALYSIS; CLINICAL TRIAL; CYSTIC FIBROSIS; DIMENSIONAL MEASUREMENT ACCURACY; LUNG; PATHOPHYSIOLOGY; PROCEDURES;

SODIUM CHLORIDE;

CYSTIC FIBROSIS; DIMENSIONAL MEASUREMENT ACCURACY; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INFANT; LUNG; MALE; RESPIRATORY FUNCTION TESTS; SODIUM CHLORIDE;

EID: 84964992868     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2015.10.007     Document Type: Article

References (23)

1. Sly P.D., Brennan S., Gangell C., de Klerk N., Murray C., Mott L., et al. Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med 2009, 180:146-152.
2. Sly P.D., Gangell C.L., Chen L., Ware R.S., Ranganathan S., Mott L.S., et al. Risk factors for bronchiectasis in children with cystic fibrosis. N Engl J Med 2013, 368:1963-1970.
3. Ranganathan S.C., Stocks J., Dezateux C., Bush A., Wade A., Carr S., et al. The evolution of airway function in early childhood following clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med 2004, 169:928-933.
4. Linnane B.M., Hall G.L., Nolan G., Brennan S.M., Sly P.D., Robertson C.F., et al. Lung function in infants with cystic fibrosis diagnosed by newborn screening. Am J Respir Crit Care Med 2008, 178:1238-1244.
5. Pillarisetti N., Williamson E., Linnane B., Skoric B., Robertson C.F., Robinson P., Massie J., et al. Infection, inflammation, and lung function decline in infants with cystic fibrosis. Am J Respir Crit Care Med 2011, 184:75-81.
6. Davis S.D., Rosenfeld M., Kerby G.S., Brumback L., Kloster M.H., Acton J.D., et al. Multicenter evaluation of infant lung function tests as cystic fibrosis clinical trial endpoints. Am J Respir Crit Care Med 2010, 182:1387-1397.
7. Rosenfeld M., Ratjen F., Brumback L., Daniel S., Rowbotham R., McNamara S., et al. Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial. JAMA 2012, 307:2269-2277.
8. Aurora P., Bush A., Gustafsson P., Oliver C., Wallis C., Price J., et al. Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis. Am J Respir Crit Care Med 2005, 171:249-256.
9. Aurora P., Gustafsson P., Bush A., Lindblad A., Oliver C., Wallis C.E., et al. Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis. Thorax 2004, 59:1068-1073.
10. Hoo A.F., Thia L.P., Nguyen T.T.D., Bush A., Chudleigh J., Lum S., et al. On behalf of the LCFC. Lung function is abnormal in 3-month-old infants with cystic fibrosis diagnosed by newborn screening. Thorax 2012, 67:874-881.
11. Matecki S., Kent L., de Boeck K., Le Bourgeois M., Zielen S., Braggion C., et al. Is the raised volume rapid thoracic compression technique ready for use in clinical trials in infants with cystic fibrosis?. J Cyst Fibros 2016, 15:10-20.
12. Elkins M.R., Robinson M., Rose B.R., Harbour C., Moriarty C.P., Marks G.B., et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 2006, 354:229-240.
13. Davis S.D., Rosenfeld M., Brumback L., Donaldson S., Johnson R., Rowbotham R., et al. The ISIS Study Group, Infant PFTs as an Endpoint in the Infant Study of Inhaled Saline Randomized Controlled Trial. Pediatr Pulmonol Suppl 2012, 12:302.
14. Stocks J., Godfrey S., Beardsmore C., Bar-Yishay E., Castile R. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society/American Thoracic Society. Plethysmographic measurements of lung volume and airway resistance. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society/ American Thoracic Society. Eur Respir J 2001, 17:302-312.
15. Castile R., Filbrun D., Flucke R., Franklin W., McCoy K. Adult-type pulmonary function tests in infants without respiratory disease. Pediatr Pulmonol 2000, 30:215-227.
16. ATS/ERS statement: raised volume forced expirations in infants. Am J Respir Crit Care Med 2005, 172:1463-1471.
17. Jones M., Castile R., Davis S., Kisling J., Filbrun D., Flucke R., et al. Forced expiratory flows and volumes in infants. Normative data and lung growth. Am J Respir Crit Care Med 2000, 161:353-359.
18. Quittner A.L., Sawicki G.S., McMullen A., Rasouliyan L., Pasta D.J., Yegin A., et al. Erratum to: psychometric evaluation of the Cystic Fibrosis Questionnaire-Revised in a national, US sample. Qual Life Res Int J Qual Life Asp Treat Care Rehab 2012, 21:1279-1290.
19. Brumback L.C., Baines A., Ratjen F., Davis S.D., Daniel S.L., Quittner A.L., et al. Pulmonary exacerbations and parent-reported outcomes in children <6 years with cystic fibrosis. Pediatr Pulmonol 2014, 50(3):236-243.
20. Alpern A.N., Brumback L.C., Ratjen F., Rosenfeld M., Davis S.D., Quittner A.L. Initial evaluation of the Parent Cystic Fibrosis Questionnaire-Revised (CFQ-R) in infants and young children. J Cyst Fibros 2015, 14(3):403-411.
21. Nguyen T.T.D., Thia L.P., Hoo A.F., Bush A., Aurora P., Wade A., et al. Evolution of lung function during the first year of life in newborn screened cystic fibrosis infants. Thorax 2014, 69:910-917.
22. Lum S., Gustafsson P., Ljungberg H., Hulskamp G., Bush A., Carr S.B., et al. Early detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume tests. Thorax 2007, 62:341-347.
23. Subbarao P., Stanojevic S., Brown M., Jensen R., Rosenfeld M., Davis S., et al. Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline. Am J Respir Crit Care Med 2013, 188:456-460.